Optimising radioiodine therapy strategies for thyroid cancer in Japan

Optimising radioiodine therapy strategies for thyroid cancer in Japan - Optimising radioiodine therapy strategies for thyroid cancer in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059253

Enrollment

400

Registered

2025-10-01

Start date

2019-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with thyroid cancer who underwent total thyroidectomy and required radioiodine therapy

Exclusion criteria

Exclusion criteria: Patients with unknown medical history

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Progression free survival Preservation of good health and quality of life	—

Countries

Japan

Contacts

Public ContactRieko Nakatani

Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism

rieko425@koto.kpu-m.ac.jp+81-75-251-5505

Outcome results